 "Vivimed Labs extends rally on stake buy by investor Ashish Kacholia")
Vivimed Labs has rallied 12% to Rs 115 on the National Stock Exchange (NSE) in intra-day on Wednesday, extending its Tuesday’s 20% surge, after investor Ashish Kacholia acquired nearly two percentage point stake in the pharmaceuticals company through open market.
On September 27, Ashish Kacholia purchased 1.37 million equity shares representing 1.7% of total equity of Vivimed Labs at an average price of Rs 90.50 per share, the NSE bulk deal data shows.
RBA Finance & Investment also bought 2.2 million shares or 2.74% stake in the company at price of Rs 90.5 per share.
Nylim Jacob Ballas India Fund III LLC had sold part of its holding via open market. It offloaded 4.88 million shares representing 6% of total equity of Vivimed Labs at an average price of Rs 93.65 per share, data shows. LINK
The name of the other buyers not ascertained.
As per shareholding pattern data as of June 30, 2016, Nylim Jacob Ballas India Fund III LLC held 10.63 million or 13.13% stake in the company.
The stock hit a 52-week high in intra-day trade, rallied 60% from its recent low of Rs 72 touched on September 8.
At 10:16 am, the stock was up 6% at Rs 109 on the NSE. The trading volumes on the counter jumped more than two-fold with a combined 6.88 million shares changed hands on the BSE and NSE so far.
On September 27, Ashish Kacholia purchased 1.37 million equity shares representing 1.7% of total equity of Vivimed Labs at an average price of Rs 90.50 per share, the NSE bulk deal data shows.
RBA Finance & Investment also bought 2.2 million shares or 2.74% stake in the company at price of Rs 90.5 per share.
Nylim Jacob Ballas India Fund III LLC had sold part of its holding via open market. It offloaded 4.88 million shares representing 6% of total equity of Vivimed Labs at an average price of Rs 93.65 per share, data shows. LINK
The name of the other buyers not ascertained.
As per shareholding pattern data as of June 30, 2016, Nylim Jacob Ballas India Fund III LLC held 10.63 million or 13.13% stake in the company.
The stock hit a 52-week high in intra-day trade, rallied 60% from its recent low of Rs 72 touched on September 8.
At 10:16 am, the stock was up 6% at Rs 109 on the NSE. The trading volumes on the counter jumped more than two-fold with a combined 6.88 million shares changed hands on the BSE and NSE so far.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%